Longevity Fund: Investing In A Future Of Long Life

The Longevity Fund is an investment vehicle that focuses on companies working to improve human longevity and healthy ageing. Founded in 2011, the fund has supported companies developing drugs and treatments for age-related diseases. Longevity funds, including the Longevity Pension Fund, are designed to provide lifetime income to retirees, with the potential for income growth over time. These funds are becoming increasingly popular as life expectancy rises worldwide, and investors seek to profit from longevity trends through specialised exchange-traded funds (ETFs). While investing in longevity funds may offer attractive opportunities, it is important to exercise caution as these funds are considered risky, and investors should consult professional financial advisors before making any investment decisions.

Longevity funds: investing in human longevity

The Longevity Fund, founded in 2011, is a venture capital fund that invests in human longevity, specifically targeting companies developing drugs for age-related diseases and longevity. The fund's strategy is based on the belief that increasing healthy human lifespan is the most important milestone for the industry. The longevity field is expected to play out in three stages: pioneers, dominant players, and generic players. The fund aims to support companies in the early stages of this process, providing financial returns and bringing plausible drug candidates to patients.

One example of a longevity fund is the Longevity Pension Fund, a mutual fund designed to provide lifetime income to Canadian retirees. This fund offers monthly distributions with expected increases over time, providing retirees with peace of mind and helping them achieve their retirement goals. It also provides complete access to unpaid capital, allowing investors to change their minds and redeem their original investment if needed.

Longevity funds, in general, are a new type of investment vehicle that focuses on companies and sectors contributing to higher-quality, longer lives. These funds invest in a range of areas, including healthcare, financial services for longer lives, aging in place, self-driving vehicles, and long-term care technologies. The core idea behind these funds is that living longer is beneficial for individuals, society, and the economy, but only if those extra years are spent in good health and without financial worries.

The emergence of longevity funds reflects the increasing life expectancy worldwide and the recognition that longevity is a significant force shaping the global economy. As a result, investors are now considering longevity as a compelling theme, similar to environmental, social, and governance (ESG) investing. However, it is important to approach longevity investments with caution, as they are still relatively new and carry a certain level of risk.

When considering investing in longevity funds, it is essential to consult professional financial advisors to assess your unique circumstances and determine if this type of investment aligns with your financial goals and risk tolerance.

Longevity pension funds: income for life

The Longevity Pension Fund is a mutual fund designed to provide lifetime income to Canadian retirees. It is the first income-for-life mutual fund designed for Canadians in retirement, addressing the growing social challenge of income security for retirees. The fund is similar in design to a defined-benefit pension but distinguishes itself from other mutual fund products by incorporating longevity risk pooling to provide lifetime income.

The fund includes two classes: the Accumulation Class and the Decumulation Class. The former is for investors under 65 who are still saving for retirement, while the latter is for individuals 65 and over who are retired and seeking income. The fund provides flexibility, allowing investors to redeem or invest more at any time. It also offers the security of a pension, with monthly distributions designed to increase over time.

The Longevity Pension Fund is trusted by experts and backed by financial support from OMERS Pension Plan and Allianz. It is guided by a Longevity Advisory Committee, comprising world-renowned experts in retirement, pension plan design, actuarial science, financial planning, and pension investing and operations. This committee provides feedback on critical fund decisions and explores ways to expand the fund offering to help Canadians retire more confidently.

The fund is available to all Canadian investors and can be held in both registered and non-registered accounts, such as RRSP, RRIF, LIF, and TFSA. It is also eligible to be held within self-directed accounts or through financial planners or investment advisors.

Longevity funds: investing in companies that benefit from healthy ageing

The idea of investing in longevity trends is becoming increasingly popular, with money managers devising ways for investors to profit from longevity trends through specialised exchange-traded funds or ETFs. Longevity funds invest in companies that could benefit from healthy ageing, financial services for longer lives, self-driving vehicles, and technologies that aid long-term care or other sectors contributing to higher-quality lives with longer life spans.

The core idea behind longevity funds is that living longer is only beneficial if the extra years are enjoyed in good health and without financial worries. As life expectancy rises worldwide, longevity has become one of the most significant forces shaping the global economy, presenting multi-trillion-dollar opportunities to reshape societies.

One of the earliest longevity funds is The Longevity Fund, founded in 2011 by Laura Deming. The fund has supported some of the first companies in the space to IPO and develop plausible drug candidates for patients with age-related diseases. The fund's strategy is focused on three stages: Pioneers, Dominant players, and Generic players. The Pioneers stage (2013-2023) involves demonstrating the financial viability of longevity companies and developing reasonable drug candidates for age-related diseases. The Dominant players stage (2023-2050) will see the emergence of top founders in the field, who will have the resources to create companies that develop the first approved longevity drugs, enter major biotech leagues, and scale to impact how 50+ year-olds plan their lives. By 2050, developing drugs for longevity will become mainstream, attracting substantial public and private funding, and large pharma companies will have dedicated teams for longevity research.

Another example of a longevity fund is the Longevity Pension Fund, a mutual fund designed to provide lifetime income to Canadian retirees. The fund offers two classes: the Accumulation Class for investors under 65 who are still saving for retirement, and the Decumulation Class for individuals 65 and over who are retired and seeking income. The fund can be purchased through licensed financial advisors, wealth management firms, and discount/direct brokerages in Canada.

While investing in longevity funds may be promising, it is important to approach with caution as these investments are relatively new and carry risks. Thematic funds, including longevity ETFs, are considered risky as their success depends on strong investment themes and the ability of portfolio managers to select the right stocks at the right prices before the market recognises their potential.

Longevity funds: investing in financial services for longer lives

The Longevity Pension Fund is a mutual fund that provides lifetime income to Canadian retirees. The fund offers two classes: the Accumulation Class for investors under 65 who are still saving for retirement, and the Decumulation Class for individuals 65 and over who are already retired. The fund can be purchased through licensed financial advisors, wealth management firms, or discount/direct brokerages. It is important to note that distributions are not guaranteed and may fluctuate based on market conditions and other factors.

The core idea behind longevity funds is that living longer is beneficial for individuals, society, and the economy, but only if those extra years are spent in good health and without financial worries. Longevity funds invest in companies that promote healthy ageing, financial services for longer lives, ageing in place, and technologies that aid long-term care. For example, cosmetic companies are starting to market their products to older adults, and tech companies are using AI to improve long-term care at home.

When considering investing in longevity funds, it is essential to understand the risks involved. Thematic funds, including longevity-themed funds, are considered risky investments. While investor interest in thematic funds has grown significantly in recent years, it is crucial to remember that the success of these funds depends on strong investment themes and the ability of portfolio managers to make the right stock choices at the right prices before the market recognizes their potential. Therefore, it is recommended to proceed with caution and consult professional advisors before investing.

One example of a longevity fund is the Longevity Pension Fund offered by Retire with Longevity. This fund is trusted by experts and backed by financial support from OMERS Pension Plan and Allianz. It is designed to provide Canadian retirees with income for life, with distribution levels that are expected to increase over time. The fund offers flexibility, allowing investors to change their minds and redeem the remainder of their original investment if needed. Additionally, investors can hold the fund in both registered and non-registered accounts.

In conclusion, investing in longevity funds offers an opportunity to profit from longevity trends and shape the global economy. As life expectancy rises worldwide, longevity has become a significant force that can potentially reshape societies for the better. However, it is essential to carefully consider the risks and consult financial advisors before making any investment decisions.

Longevity funds: investing in self-driving vehicles and long-term care technology

Longevity funds are a relatively new type of investment vehicle that has emerged as life expectancy has risen globally. These funds aim to profit from trends in healthy ageing, financial services for longer lives, and technologies that aid long-term care. The core idea behind longevity funds is that living longer is beneficial for individuals, society, and the economy, but only if those extra years are spent in good health and without financial worries.

One area that longevity funds are investing in is self-driving vehicles. As people live longer, the need for safe and reliable transportation options becomes more critical. Self-driving vehicles offer a solution by providing mobility for those who may no longer be able to drive or prefer not to. Additionally, self-driving vehicles have the potential to revolutionise transportation, making it safer and more efficient. Investing in self-driving vehicles also makes financial sense, as it is expected to impact sectors worth trillions of dollars.

Some of the top companies to consider when investing in self-driving vehicles include Alphabet (parent company of Google and Waymo), Amazon (owner of robotaxi startup Zoox), Tesla (known for its electric vehicles and autonomous driving technology), Nvidia (a leader in semiconductor design and AI platform for self-driving cars), and Qualcomm (providing mobility chips and software for the auto industry). These companies are at the forefront of self-driving technology and are expected to drive innovation and growth in this sector.

Another area of focus for longevity funds is long-term care technology. As people age, they may require additional support to maintain their health and independence. Long-term care technology aims to provide solutions that improve the quality of life for older adults and reduce the burden on caregivers. One example of this is brain-computer interfaces (BCIs), which can be used to develop bionic limbs, treat paralysis and serious brain diseases, and enhance cognition. While funding in this area is still sparse, it has the potential to make a significant impact on the lives of those with disabilities.

Other technologies that fall under the umbrella of long-term care include bioprinting, which could revolutionise organ transplants and create living tissue, and AI-assisted reproductive technologies, which can improve success rates in IVF treatments. Longevity funds that invest in these areas are betting on the potential for these technologies to improve the quality of life for older adults and those with health challenges.

In conclusion, investing in longevity funds that focus on self-driving vehicles and long-term care technology offers a unique opportunity to profit from trends in healthy ageing and innovative technologies. While these investments may carry a higher risk, the potential rewards are significant, and they contribute to the broader goal of improving the quality of life for individuals and society as a whole.

Frequently asked questions